Other
Embryo
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Embryo is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
11
clinical trials
Completed8 · 73%
Terminated2 · 18%
Unknown status1 · 9%
Clinical Trials
Trial Activity
11 trials
Comparison of Two Embryo Culture Media for IVF and ICSI
Completed·—·N/A·NCT02586324·1,000 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)